Clinical Trial Update: A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment [Phase 2]

View source ↗

Summary

A Phase 2 dose-response trial of rFSH FE 999049 in women undergoing IVF/ICSI has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• rFSH FE 999049

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Phase 2 | Status: COMPLETED | Results posted: 2018-08-03